Viewing Study NCT04896957


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2025-12-29 @ 6:54 AM
Study NCT ID: NCT04896957
Status: COMPLETED
Last Update Posted: 2022-12-02
First Post: 2021-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Perceptions and Representations of Vaccination Against COVID-19
Sponsor: Centre Hospitalier Intercommunal Creteil
Organization:

Study Overview

Official Title: Perceptions and Representations of Vaccination Against COVID-19
Status: COMPLETED
Status Verified Date: 2022-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PERCECOVAC
Brief Summary: SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fundamental, that is why vaccines have been developed. In France, this vaccination campaign took place in a context where the lack of confidence in vaccination is high:

According to a November 2020 IFOP poll, only 41% of French respondents were willing to be vaccinated against COVID-19.

To our knowledge, there are still few qualitative studies on vaccination on the current issue of vaccination against COVID-19.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: